Basic Information
LncRNA/CircRNA Name | CASC15 |
Synonyms | NA |
Region | GRCh38_6:21664772-22368328 |
Ensemble | ENSG00000272168 |
Refseq | NR_015410 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | qPCR, Luciferase reporter assay, in vitro knockdown |
Sample | The PC cell lines (LNCaP, DU145 and 22Rv1) and normal human prostate epithelial cell line (P69), PC tissue, adjacent tissues |
Expression Pattern | up-regulated |
Function Description | CASC15 expression level was significantly higher in PC tissues and cell lines. Results of wound healing assay and transwell assay revealed that cell migrated ability and invaded ability were suppressed via silence of CASC15 in PC cells. Furthermore, the expression of miR-200a-3p was upregulated via silence of CASC15 in PC cells. Luciferase assay showed that miR-200a-3p was a direct target of CASC15 in PC. In addition, miR-200a-3p expression was negatively correlated with CASC15 expression in PC tissues. Rescue experiments also revealed that the inhibition of PC migration and invasion by silence of CASC15 could be reversed through knockdown of miR-200a-3p. |
Pubmed ID | 31646560 |
Year | 2019 |
Title | LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p |
External Links
Links for CASC15 | GenBank HGNC NONCODE |
Links for prostate cancer | OMIM COSMIC |